Mirna Rapp

Title: Mirna Rapp: Innovator in Fibrin-Based Medical Solutions

Introduction

Mirna Rapp, an accomplished inventor based in Marburg, Germany, has made significant contributions to the field of biomedical engineering with her innovative solutions in wound healing. With a portfolio of three patents, her work focuses on advanced fibrin adhesive technologies that demonstrate potential for application in surgical and tissue therapies.

Latest Patents

Her latest patents include a formulation titled "Fibrin adhesive granulate and method for its preparation." This invention details a flowable fibrin adhesive granulate composed of thrombin, Factor XIII, fibrinogen, and a calcium salt. The granules, ranging in size from more than 50 µm to 1000 µm, are engineered for effective wound healing, offering enhanced support in surgical procedures and biological treatments. Additionally, Mirna’s innovations encompass an effervescent granulate and powder designed to create a foam suitable for hemostasis, as well as preparations that integrate a non-woven fabric coated with a biodegradable fibrin glue granulate mixture to arrest bleeding.

Another notable patent is her work on a "Flexible wound covering based on fibrin and process for its production." This patent describes the creation of a biodegradable and flexible wound covering derived from fibrin, utilizing a unique process involving dialysis of a fibrinogen solution, followed by the formation of a fibrin web through thrombin addition, and concluding with freeze-drying.

Career Highlights

Mirna has collaborated with leading companies in the biopharma industry, including Aventis Behring GmbH and CSL Behring GmbH, where she has been able to cultivate her expertise and contribute to groundbreaking developments in medical adhesion technologies. Her experience in these institutions reflects her commitment to advancing medical solutions that prioritize patient care.

Collaborations

Throughout her career, Mirna Rapp has worked alongside notable professionals such as Armin Prasch and Bernhard Luy. These collaborations have allowed her to enhance the innovation process and achieve significant milestones in her field.

Conclusion

Mirna Rapp stands out as a prominent inventor whose work in fibrin-based technologies continues to push the boundaries of medical innovation. Her patents serve as a testament to her dedication to improving surgical outcomes and advancing healthcare solutions. As she progresses in her career, the impact of her inventions will undoubtedly resonate within the medical community and beyond.